Drug intelligence / Profile preview

Weiyan No. 1 Granules

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Weiyan No. 1 Granules is a compound pharmaceutical preparation indicated for the treatment of chronic superficial gastritis and gastric ulcers. It combines the antibacterial action of Gentamicin Sulfate, the local anesthetic effect of Procaine Hydrochloride, and the mucosal repair properties of Vitamin B12. Gentamicin Sulfate inhibits bacterial protein synthesis, including that of Helicobacter pylori, while Procaine Hydrochloride provides pain relief by blocking sodium ion channels in nerve fibers. Vitamin B12 supports the formation of normal epithelial cells, aiding in gastric mucosal healing. The drug is administered orally and works to alleviate symptoms, combat bacterial infections, and promote the repair of damaged gastric lining.

Other names
胃炎1号颗粒剂Gastritis Granules胃炎颗粒
02

Targets

NeuraminidaseNaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Weiyan No. 1 Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weiyan No. 1 Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call